Cargando…

Transthyretin as a Biomarker to Predict and Monitor Major Depressive Disorder Identified by Whole-Genome Transcriptomic Analysis in Mouse Models

Background: Accumulations of stressful life events result in the onset of major depressive disorder (MDD). Comprehensive genomic analysis is required to elucidate pathophysiological changes and identify applicable biomarkers. Methods: Transcriptomic analysis was performed on different brain parts of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Sung-Liang, Chu, Selina Shih-Ting, Chien, Min-Hui, Kuo, Po-Hsiu, Yang, Pan-Chyr, Su, Kang-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469805/ https://www.ncbi.nlm.nih.gov/pubmed/34572310 http://dx.doi.org/10.3390/biomedicines9091124

Ejemplares similares

Alteration of transthyretin and thyroxine-binding globulin in major depressive disorder: multiple reaction monitoring-based proteomic analysis
por: Woo, Hye In, et al.
Publicado: (2021)

A Deep Learning Approach for Predicting Antidepressant Response in Major Depression Using Clinical and Genetic Biomarkers
por: Lin, Eugene, et al.
Publicado: (2018)

Transthyretin Is Commonly Upregulated in the Hippocampus of Two Stress-Induced Depression Mouse Models
por: Saito-Takatsuji, Hidehito, et al.
Publicado: (2023)

A comprehensive network and pathway analysis of candidate genes in major depressive disorder
por: Jia, Peilin, et al.
Publicado: (2011)

Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management
por: Vélez-Santamaría, Valentina, et al.
Publicado: (2022)

Prediction of Probable Major Depressive Disorder in the Taiwan Biobank: An Integrated Machine Learning and Genome-Wide Analysis Approach
por: Lin, Eugene, et al.
Publicado: (2021)

Sparse whole genome sequencing identifies two loci for major depressive disorder
Publicado: (2015)

Exploration of the relationship between gut microbiota and fecal microRNAs in patients with major depressive disorder
por: Chen, Hui-Mei, et al.
Publicado: (2022)

Salivary Proteomics Identifies Transthyretin as a Biomarker of Early Dementia Conversion
por: Eldem, Ece, et al.
Publicado: (2022)

Integrated Analysis of Methylomic and Transcriptomic Data to Identify Potential Diagnostic Biomarkers for Major Depressive Disorder
por: Xie, Yinping, et al.
Publicado: (2021)

How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage
por: Izumiya, Yasuhiro, et al.
Publicado: (2020)

EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
por: Zou, Huizhen, et al.
Publicado: (2023)

Identifying circulating biomarkers for major depressive disorder
por: Zhang, En, et al.
Publicado: (2023)

Monitoring for arrhythmia in transthyretin cardiac amyloidosis with remote patch devices
por: Bruce, S, et al.
Publicado: (2023)

Functional connectivity analysis on electroencephalography signals reveals potential biomarkers for treatment response in major depression
por: Huang, Shiau-Shian, et al.
Publicado: (2023)

Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
por: Morfino, Paolo, et al.
Publicado: (2023)

Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia
por: Lin, Weiqin, et al.
Publicado: (2022)

Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy
por: Rettl, René, et al.
Publicado: (2023)

High-Coverage Whole-Exome Sequencing Identifies Candidate Genes for Suicide in Victims with Major Depressive Disorder
por: Tombácz, Dóra, et al.
Publicado: (2017)

A Whole Transcriptome Analysis in Peripheral Blood Suggests That Energy Metabolism and Inflammation Are Involved in Major Depressive Disorder
por: Wang, Yu, et al.
Publicado: (2022)

Genomic Screening Identifies Individuals at High Risk for Hereditary Transthyretin Amyloidosis
por: Soper, Emily R., et al.
Publicado: (2021)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
por: Yamaguchi, Hiroki, et al.
Publicado: (2022)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022)

Monitoring Tafamidis, The Most Expensive Cardiac Medication: Are Serum Transthyretin Levels the Answer?
por: Chang, Ian C., et al.
Publicado: (2021)

Monitoring the Patient with Retinal Angiopathy Associated with Hereditary Transthyretin Amyloidosis: Current Perspectives
por: Marques, João Heitor, et al.
Publicado: (2022)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer's disease?
por: Li, Xinyi, et al.
Publicado: (2011)

The Importance of a Gatekeeper Residue on the Aggregation of Transthyretin: IMPLICATIONS FOR TRANSTHYRETIN-RELATED AMYLOIDOSES
por: Sant'Anna, Ricardo, et al.
Publicado: (2014)

Transthyretin as a novel candidate biomarker for preeclampsia
por: ZHU, LEI, et al.
Publicado: (2014)

The Extracellular Protein, Transthyretin Is an Oxidative Stress Biomarker
por: Sharma, Meesha, et al.
Publicado: (2019)

Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining
por: Abouelhoda, Mohamed, et al.
Publicado: (2021)

Phenotypic expressions of hereditary Transthyretin Ala97Ser related Amyloidosis (ATTR) in Taiwanese
por: Hsu, Hui-Ching, et al.
Publicado: (2017)

Global Transcriptome Analysis During Adipogenic Differentiation and Involvement of Transthyretin Gene in Adipogenesis in Cattle
por: Cai, Hanfang, et al.
Publicado: (2018)

Integrative Genome-Wide Association Studies of eQTL and GWAS Data for Gout Disease Susceptibility
por: Lee, Meng-tse Gabriel, et al.
Publicado: (2019)

Pitfalls for the non-invasive diagnosis of wild-type transthyretin amyloid cardiomyopathy in a young adult: a case report
por: Chang, Hao-Chih, et al.
Publicado: (2023)

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017)

A latent genetic subtype of major depression identified by whole-exome genotyping data in a Mexican-American cohort
por: Yu, C, et al.
Publicado: (2017)

Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis
por: Hein, Selina J, et al.
Publicado: (2021)

Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity
por: Pantazatos, Spiro P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a8akd9cfrhp9fjbprhldpau7q7